We see personalized cancer medicine as the future of patient care and we believe that nothing can be truly personalized unless the active dose in each patient is assessed. With the help of an easy and accurate measurement, current methods can be adjusted to give both a higher patient safety and a higher efficiency.
That each patient gets the optimal dose should be taken for granted, not be a utopia.
We hope to be able to implement TailorDose as part of the standard care routine in patients treated with toxic drugs with small therapeutic windows. TailorDose is currently used in ongoing clinical trials with the goal to prove a significant correlation between active dose and severe toxic side effects.